Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar;37(3):186-189;196.
doi: 10.13201/j.issn.2096-7993.2023.03.006.

[Diagnosis and treatment of congenital temporal bone cholesteatoma]

[Article in Chinese]
Affiliations
Review

[Diagnosis and treatment of congenital temporal bone cholesteatoma]

[Article in Chinese]
Yalan Li et al. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2023 Mar.

Abstract

Congenital temporal bone cholesteatoma is a rare lesion in otolaryngology.The disease is locally invasive and may lead to significant complications,including hearing loss(conductive or sensorineural), temporal bone destruction and intracranial invasion. This article reviews the characteristic symptoms of congenital temporal bone cholesteatoma, testing and imaging of the disease, stage and the current treatment options in order to promote awareness to this rare disease entity and perform early surgical treatment, effectively avoid the destruction of the temporal bone and its surrounding structures, thereby reducing the occurrence of complications. By improving the understanding of the disease and performing early surgical treatment, the destruction of the temporal bone and its surrounding structures can be effectively avoided, thereby reducing the occurrence of complications.

摘要: 先天性颞骨胆脂瘤是耳鼻喉科的罕见疾病,具有侵袭性,可能导致包括听力损失(传导性或感音神经性)、颞骨破坏以及颅内侵犯等严重并发症。本文回顾了先天性颞骨胆脂瘤的临床表现、影像学特征、分期和目前的治疗方案,以期提高认识,及时进行手术治疗,避免胆脂瘤对于颞骨及周围结构的破坏,从而减少并发症。.

Keywords: congenital temporal bone cholesteatoma; endoscope; middle ear; petrous bone.

PubMed Disclaimer

Conflict of interest statement

The authors of this article and the planning committee members and staff have no relevant financial relationships with commercial interests to disclose.

Similar articles

Cited by

References

    1. Jang HB, Lee JM, Kim DJ, et al. Treatment results for congenital cholesteatoma using transcanal endoscopic ear surgery. Am J Otolaryngol. 2022;43(5):103567. doi: 10.1016/j.amjoto.2022.103567. - DOI - PubMed
    1. Orobello N, Harrington C, Reilly BK. Updates in paediatric cholesteatoma. Curr Opin Otolaryngol Head Neck Surg. 2022;30(6):422–425. doi: 10.1097/MOO.0000000000000850. - DOI - PubMed
    1. McCabe R, Lee DJ, Fina M. The Endoscopic Management of Congenital Cholesteatoma. Otolaryngol Clin North Am. 2021;54(1):111–123. doi: 10.1016/j.otc.2020.09.012. - DOI - PubMed
    1. Kuo CL, Shiao AS, Yung M, et al. Updates and knowledge gaps in cholesteatoma research. Biomed Res Int. 2015;2015:854024. - PMC - PubMed
    1. Gilberto N, Custódio S, Colaço T, et al. Middle ear congenital cholesteatoma: systematic review, meta-analysis and insights on its pathogenesis. Eur Arch Otorhinolaryngol. 2020;277(4):987–998. doi: 10.1007/s00405-020-05792-4. - DOI - PubMed

Supplementary concepts

LinkOut - more resources